Arcutis Biotherapeutics Overview
Arcutis Biotherapeutics Target Price
Analysts' 12-month price predictions for ARQT.
Get informed when a big investor buys or sells
+ FollowShare Price
$25.81
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-02-26 | H.C. WainwrightDoug Tsao | $34 |  31.7% upside |  |
| 2025-11-28 | Mizuho SecuritiesUy Ear | $37 | 43.4% upside | |
| 2025-10-30 | Goldman SachsRichard Law | $29 | 12.4% upside | |
| 2025-10-29 | H.C. WainwrightDouglas Tsao | $30 | 16.2% upside | |
| 2025-10-29 | Mizuho SecuritiesUy Ear | $32 | 24% upside | |
| 2025-03-11 | Jefferies | $19 |  26.4% downside | |
| 2024-12-30 | H.C. WainwrightDouglas Tsao | $19 | 26.4% downside | |
| 2024-05-15 | NeedhamSerge Belanger | $18 | 30.3% downside | |
| 2024-05-15 | Mizuho SecuritiesUy Ear | $18 | 30.3% downside | |
| 2024-01-02 | Mizuho Securities | $8 | 69% downside | |
| 2022-12-13 | Morgan Stanley | $51 | 97.6% upside | |
| 2022-04-27 | Goldman SachsEric Cha | $37 | 43.4% upside | |